Methadone hydrochloride and Ceftazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methadone hydrochloride (methadone hydrochloride) and Ceftazidime (ceftazidime). Common drug interactions include injury among females and foetal exposure during pregnancy among males.

The phase IV clinical study analyzes what interactions people have when they take Methadone hydrochloride and Ceftazidime. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Methadone hydrochloride?

Methadone hydrochloride has active ingredients of methadone hydrochloride. It is often used in pain. eHealthMe is studying from 8,598 Methadone hydrochloride users. Check the latest studies of Methadone hydrochloride.

What is Ceftazidime?

Ceftazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,327 Ceftazidime users. Check the latest studies of Ceftazidime.



On Jul, 27, 2026

19 people who take Methadone hydrochloride and Ceftazidime together, and have interactions are studied.

Methadone hydrochloride and Ceftazidime drug interactions.

What are the common drug interactions of Methadone Hydrochloride and Ceftazidime, by gender? *:

female:

  1. Injury
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Abdominal discomfort
  4. Abdominal distension
  5. Abdominal pain
  6. Anxiety
  7. Ascites (accumulation of fluid in the abdominal cavity)
  8. Asthenia (weakness)
  9. Colon adenoma (non cancerous epithelial colon tumour having a glandular origin and structure)
  10. Colonic polyp (extra part of colon tissue grow in intestine)

male:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Foetal growth restriction (poor growth of a baby while in the mother's womb during pregnancy)
  3. Hypokalaemia (low potassium)
  4. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  5. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  6. Metastases to meninges (cancer spreads to meninges)
  7. Muscular weakness (muscle weakness)
  8. Primitive neuroectodermal tumour (neural crest tumour)
  9. Pulse absent
  10. Pyrexia (fever)

What are the common drug interactions of Methadone Hydrochloride and Ceftazidime, by age (0-1 to 60+)? *:

0-1:

  1. Hypokalaemia (low potassium)
  2. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  3. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  4. Primitive neuroectodermal tumour (neural crest tumour)
  5. Respiratory distress (difficulty in breathing)
  6. Respiratory failure (inadequate gas exchange by the respiratory system)

2-9:

n/a

10-19:

  1. Abasia (inability to walk)
  2. Asthenia (weakness)
  3. Cardiac arrest
  4. Cerebral thrombosis (blood clot in brain)
  5. Dehydration (dryness resulting from the removal of water)
  6. Diarrhoea
  7. Discomfort
  8. Grip strength decreased
  9. Metastases to meninges (cancer spreads to meninges)
  10. Muscular weakness (muscle weakness)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Injury
  2. Pulmonary embolism (blockage of the main artery of the lung)

60+:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  5. Hepatomegaly (abnormal enlargement of the liver)
  6. Hypokalaemia (low potassium)
  7. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  8. Jaundice cholestatic
  9. Joint swelling
  10. Metastases to liver (cancer spreads to liver)

What are the existing conditions these people have? *

  1. Moraxella Infection (bacterial infection): 13 people, 68.42%
  2. Hiv Infection: 13 people, 68.42%
  3. Bacteraemia (presence of bacteria in the blood): 13 people, 68.42%
  4. Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 13 people, 68.42%
  5. Foetal Exposure During Pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect): 5 people, 26.32%
  6. Primitive Neuroectodermal Tumor: 1 person, 5.26%
  7. Osteoporosis (bones weak and more likely to break): 1 person, 5.26%
  8. Nausea (feeling of having an urge to vomit): 1 person, 5.26%
  9. Dysfunctional Uterine Bleeding (Dub): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Methadone hydrochloride and Ceftazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methadone hydrochloride and Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methadone hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ceftazidime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methadone hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ceftazidime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methadone hydrochloride and ceftazidime (the active ingredients of Methadone hydrochloride and Ceftazidime, respectively), and Methadone hydrochloride and Ceftazidime (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: